JP7027093B2 - Chemical volatilizer - Google Patents

Chemical volatilizer Download PDF

Info

Publication number
JP7027093B2
JP7027093B2 JP2017187934A JP2017187934A JP7027093B2 JP 7027093 B2 JP7027093 B2 JP 7027093B2 JP 2017187934 A JP2017187934 A JP 2017187934A JP 2017187934 A JP2017187934 A JP 2017187934A JP 7027093 B2 JP7027093 B2 JP 7027093B2
Authority
JP
Japan
Prior art keywords
sealed bag
drug
container
bag
resin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2017187934A
Other languages
Japanese (ja)
Other versions
JP2019058612A (en
Inventor
礼 三上
諒子 大久保
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ST Corp
Original Assignee
ST Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ST Corp filed Critical ST Corp
Priority to JP2017187934A priority Critical patent/JP7027093B2/en
Priority to PCT/JP2018/029628 priority patent/WO2019064941A1/en
Publication of JP2019058612A publication Critical patent/JP2019058612A/en
Application granted granted Critical
Publication of JP7027093B2 publication Critical patent/JP7027093B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01M—CATCHING, TRAPPING OR SCARING OF ANIMALS; APPARATUS FOR THE DESTRUCTION OF NOXIOUS ANIMALS OR NOXIOUS PLANTS
    • A01M1/00—Stationary means for catching or killing insects
    • A01M1/20—Poisoning, narcotising, or burning insects
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L9/00—Disinfection, sterilisation or deodorisation of air
    • A61L9/015—Disinfection, sterilisation or deodorisation of air using gaseous or vaporous substances, e.g. ozone
    • A61L9/04—Disinfection, sterilisation or deodorisation of air using gaseous or vaporous substances, e.g. ozone using substances evaporated in the air without heating
    • A61L9/12—Apparatus, e.g. holders, therefor
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D77/00—Packages formed by enclosing articles or materials in preformed containers, e.g. boxes, cartons, sacks or bags
    • B65D77/04—Articles or materials enclosed in two or more containers disposed one within another
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D83/00—Containers or packages with special means for dispensing contents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D85/00—Containers, packaging elements or packages, specially adapted for particular articles or materials

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Health & Medical Sciences (AREA)
  • Pest Control & Pesticides (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Insects & Arthropods (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Catching Or Destruction (AREA)
  • Packaging Of Annular Or Rod-Shaped Articles, Wearing Apparel, Cassettes, Or The Like (AREA)
  • Disinfection, Sterilisation Or Deodorisation Of Air (AREA)
  • Packages (AREA)

Description

本発明は、例えば、芳香剤、消臭剤、防虫剤などの薬剤を揮散させるための薬剤揮散具に関する。 The present invention relates to a chemical volatilizer for volatilizing chemicals such as air fresheners, deodorants, and insect repellents.

通常、芳香剤などの揮発性を有する薬剤は、空気に触れることで揮散を開始する。このため、例えば、芳香剤を揮散容器に入れるときに、空気に触れないように芳香剤を密閉可能な袋の中に収容し、使用開始時に袋を破るようにしている。或いは、芳香剤を収容した容器の開口部をシールしておき、使用開始時にシールを破るようにしている。 Normally, volatile chemicals such as fragrances start to volatilize when exposed to air. For this reason, for example, when the fragrance is put into a volatilization container, the fragrance is stored in a sealable bag so as not to come into contact with air, and the bag is torn at the start of use. Alternatively, the opening of the container containing the fragrance is sealed so that the seal is broken at the start of use.

例えば、特許文献１の芳香剤包装体は、可撓性を有するケース内に芳香剤を収容した袋を入れた構造を有する。ケースは、その一部にガス透過性フィルムを用いている。そして、この芳香剤包装体の使用開始時に、ケースの外からケースごと袋を押して、袋を破ってガス透過性フィルムを通して芳香剤の揮散を開始する。このため、ケースを一旦開けて袋を破く必要が無く、直ぐに芳香剤の揮散を開始できる。 For example, the fragrance package of Patent Document 1 has a structure in which a bag containing the fragrance is placed in a flexible case. The case uses a gas permeable film as a part of the case. Then, at the start of use of this fragrance package, the bag is pushed together with the case from the outside of the case, the bag is broken, and the fragrance is started to volatilize through the gas permeable film. Therefore, it is not necessary to open the case once and tear the bag, and the fragrance can be immediately started to volatilize.

実開昭５８－４８２４６号公報Jitsukaisho 58-48246 Gazette

しかし、特許文献１の芳香剤包装体は、芳香剤包装体を破封して出た薬剤をガス透過性フィルムを介して揮散させるため、ガス透過性フィルムの特性上、透過が困難である薬剤も多く、薬剤選択性に制約が生じる。 However, in the fragrance package of Patent Document 1, since the drug released by breaking the fragrance package is volatilized through the gas permeable film, the drug is difficult to permeate due to the characteristics of the gas permeable film. In many cases, drug selectivity is restricted.

また、特許文献１の芳香剤包装体によると、ケースの外から袋を押すため、袋が破れたかどうか目視確認ができない。このため、芳香剤の揮散を確実に開始させることができない。 Further, according to the fragrance package of Patent Document 1, since the bag is pushed from the outside of the case, it is not possible to visually confirm whether or not the bag is torn. Therefore, it is not possible to reliably start the volatilization of the fragrance.

本発明は、上記の点に鑑みてなされたもので、薬剤の揮散を確実且つ簡単に開始させることができる薬剤揮散具を提供することを目的とする。 The present invention has been made in view of the above points, and an object of the present invention is to provide a drug volatilization tool capable of reliably and easily initiating volatilization of a drug.

本発明の薬剤揮散具の一態様は、揮発性を有する薬剤を担持した薬剤担持体を封入した密封袋と、密封袋の幅より狭い幅を有するとともに薬剤担持体が通過不能で且つ密封袋を抜き取り可能な大きさを有する抜き取り孔、及び薬剤を揮散させるための揮散孔を有し、密封袋の一部を抜き取り孔から外部へ突出させた状態で、密封袋を収容した容器と、を有する。
One aspect of the drug volatilizer of the present invention is a sealed bag in which a drug carrier carrying a volatile drug is enclosed, and a sealed bag having a width narrower than the width of the sealed bag and in which the drug carrier cannot pass through. A container having a sampling hole having a size that can be pulled out and a volatilizing hole for volatilizing a drug, and a container containing the sealed bag with a part of the sealed bag protruding outward from the sampling hole. Have.

本発明の一態様によれば、薬剤の揮散を確実且つ簡単に開始させることができる薬剤揮散具を提供することができる。 According to one aspect of the present invention, it is possible to provide a drug volatilization tool capable of reliably and easily initiating volatilization of a drug.

図１は、実施形態に係る薬剤揮散具を示す外観斜視図である。FIG. 1 is an external perspective view showing a drug volatilizer according to an embodiment. 図２は、図１の薬剤揮散具の取付例を示す概略図である。FIG. 2 is a schematic view showing an mounting example of the chemical volatilizer of FIG. 図３は、図１の薬剤揮散具の一方の容器を展開した概略斜視図である。FIG. 3 is a schematic perspective view of one container of the drug volatilizer of FIG. 1 unfolded. 図４は、図３の容器の未使用状態を示す外観図である。FIG. 4 is an external view showing an unused state of the container of FIG. 図５は、図４の容器内に収容する第１の実施形態に係る密封袋を示す外観図である。FIG. 5 is an external view showing a sealed bag according to the first embodiment to be housed in the container of FIG. 図６は、図４の未使用状態の容器をＦ６－Ｆ６に沿って切断した断面図である。FIG. 6 is a cross-sectional view of the unused container of FIG. 4 cut along F6-F6. 図７は、図６の容器に収容した密封袋を破袋させる動作を説明するための動作説明図である。FIG. 7 is an operation explanatory diagram for explaining an operation of breaking the sealed bag housed in the container of FIG. 図８は、第２の実施形態に係る密封袋を示す外観図である。FIG. 8 is an external view showing a sealed bag according to the second embodiment. 図９は、図８の密封袋を破袋させる動作を説明するための動作説明図である。FIG. 9 is an operation explanatory diagram for explaining an operation of breaking the sealed bag of FIG. 図１０は、第３の実施形態に係る密封袋を示す外観図である。FIG. 10 is an external view showing a sealed bag according to the third embodiment.

以下、本発明の実施形態について図面を参照して説明する。
図１に示すように、実施形態に係る薬剤揮散具１０は、内部が空洞の略球形の２つの容器２、４を環状のゴム紐６でつないだ構造を有する。ゴム紐６は、必ずしも環状である必要はなく１本の紐状部材であってもよく、必ずしも伸縮可能な材料により形成しなくてもよい。 Hereinafter, embodiments of the present invention will be described with reference to the drawings.
As shown in FIG. 1, the drug volatilizer 10 according to the embodiment has a structure in which two substantially spherical containers 2 and 4 having a hollow inside are connected by an annular rubber string 6. The rubber string 6 does not necessarily have to be annular, and may be a single string-shaped member, and may not necessarily be formed of a stretchable material.

一方の容器２の中には、揮発性を有する薬剤（芳香剤や消臭剤など）を封入したマイクロカプセルを担持した複数個の粒状の薬剤担持体（ここでは図示せず）が収容されている。薬剤担持体は、マイクロカプセルを用いずに薬剤を粒状の担持体に直接担持させたものであってもよく、薬剤自体を固まりにした粒状のものも薬剤担持体に含むものとする。薬剤担持体の個数、形状、大きさは、任意に設定可能であり、容器２に振動を与えたときに容器２内で移動可能であればよい。 In one container 2, a plurality of granular drug carriers (not shown here) carrying microcapsules containing volatile drugs (fragrances, deodorants, etc.) are housed. There is. The drug carrier may be one in which the drug is directly supported on the granular carrier without using microcapsules, and the granular substance in which the drug itself is agglomerated is also included in the drug carrier. The number, shape, and size of the drug carrier can be arbitrarily set, and may be movable as long as it can be moved in the container 2 when the container 2 is vibrated.

もう一方の容器４は、容器２と同じように薬剤担持体を収容してもよく、薬剤担持体を収容しなくてもよい。２つの容器２、４の大きさや形状も同じである必要はない。容器４は、内部を空洞にする必要もない。しかし、本実施形態では、容器４を容器２と同じ構造に形成し、内部に薬剤担持体を収容した。以下の説明では、一方の容器２の構造について詳細に説明し、他方の容器４の構造については、容器２と同様に機能する構成要素に同一符号を付してその詳細な説明を省略する。 The other container 4 may or may not contain the drug carrier in the same manner as the container 2. The size and shape of the two containers 2 and 4 do not have to be the same. The container 4 does not need to be hollow inside. However, in the present embodiment, the container 4 is formed to have the same structure as the container 2, and the drug carrier is housed inside. In the following description, the structure of one container 2 will be described in detail, and the detailed description of the structure of the other container 4 will be omitted by assigning the same reference numerals to the components having the same functions as the container 2.

上記の構造を有する薬剤揮散具１０は、例えば、図２に示すように、自動車のヘッドレスト１２に結び付けたり、バックミラーに括り付けたり、エアコンの吹き出し口にあるルーバーに引っ掛けて取り付けたり、後部座席の上方にあるアシストグリップに結び付けたりして使用することができる。薬剤揮散具１０は、自動車の構成部品以外のいかなる吊り下げ対象物にも取り付けできる。 As shown in FIG. 2, the chemical volatilizer 10 having the above structure can be attached to the headrest 12 of an automobile, tied to a rear-view mirror, hooked on a louver at an air conditioner outlet, or mounted on a rear seat. It can be used by connecting it to the assist grip above. The chemical volatilizer 10 can be attached to any object to be suspended other than the components of the automobile.

薬剤揮散具１０を例えば自動車の座席のヘッドレスト１２に結び付ける場合、ゴム紐６をヘッドレスト１２の一方の支柱１２ａに結び付ける。本実施形態の薬剤揮散具１０は、容器２に振動を与えることで、薬剤担持体に担持したマイクロカプセルが破袋して薬剤が揮散するものであるため、自動車などの移動体に取り付けて使用するのに適している。 When the chemical volatilizer 10 is connected to, for example, the headrest 12 of an automobile seat, the rubber cord 6 is connected to one of the columns 12a of the headrest 12. The drug volatilizer 10 of the present embodiment is used by attaching it to a moving body such as an automobile because the microcapsules carried on the drug carrier break the bag and the drug volatilizes when the container 2 is vibrated. Suitable for

以下、容器２の構造について、図３および図４を参照して説明する。
容器２は、略半球状の２つの透明な樹脂ケース２ａ、２ｂを有する。容器２は、各樹脂ケース２ａ、２ｂの開口部の縁を互いに嵌め合わせた構造を有し、内部に薬剤担持体を収容するための概ね球状の収容空間を有する。２つの樹脂ケース２ａ、２ｂは、必ずしも分離可能な構造である必要はなく、一体にしてもよい。２つの樹脂ケース２ａ、２ｂは、球を正確に半分にしたものではなく、本実施形態では、樹脂ケース２ａを樹脂ケース２ｂより若干大きく形成した。 Hereinafter, the structure of the container 2 will be described with reference to FIGS. 3 and 4.
The container 2 has two transparent resin cases 2a and 2b that are substantially hemispherical. The container 2 has a structure in which the edges of the openings of the resin cases 2a and 2b are fitted to each other, and has a substantially spherical storage space for accommodating the drug carrier inside. The two resin cases 2a and 2b do not necessarily have to have a separable structure and may be integrated. The two resin cases 2a and 2b are not exactly halved spheres, and in the present embodiment, the resin case 2a is formed slightly larger than the resin case 2b.

樹脂ケース２ａ、２ｂは、複数個の円形や星形の揮散孔２ｃを有する。揮散孔２ｃは、樹脂ケース２ａ、２ｂを貫通して設けられている。揮散孔２ｃは、必ずしも樹脂ケース２ａ、２ｂの両方に設ける必要はなく、少なくとも一方に設ければよい。或いは、後述するスリット１３を揮散孔として用いれば、必ずしも揮散孔２ｃを設ける必要もない。揮散孔２ｃの形状や大きさは、薬剤担持体が通過できない形状や大きさに設計されている。揮散孔２ｃの個数、形状、大きさは、任意に設定可能である。樹脂ケース２ａ、２ｂは、透明である必要はなく例えば樹脂ケース２ａ、２ｂの表面に絵柄を描いてもよい。 The resin cases 2a and 2b have a plurality of circular or star-shaped volatilization holes 2c. The volatilization holes 2c are provided so as to penetrate the resin cases 2a and 2b. The volatilization holes 2c do not necessarily have to be provided in both of the resin cases 2a and 2b, and may be provided in at least one of them. Alternatively, if the slit 13 described later is used as the volatilization hole, it is not always necessary to provide the volatilization hole 2c. The shape and size of the volatilization hole 2c are designed so that the drug carrier cannot pass through. The number, shape, and size of the volatilization holes 2c can be arbitrarily set. The resin cases 2a and 2b do not have to be transparent, and for example, a pattern may be drawn on the surface of the resin cases 2a and 2b.

図３に示すように、小さい方（図示右側）の樹脂ケース２ｂの開口部の縁には、縁の形状に沿った２つの円弧状に湾曲した板状の係合突起３、３が一体に突設されている。２つの係合突起３、３は、開口部の円形の縁に沿って径方向の反対側に対向して離間した位置に設けられている。各係合突起３、３の径方向の外側には、それぞれ、湾曲した２つの係合爪３ａ、３ａが設けられている。各係合突起３の２つの係合爪３ａ、３ａは、互いに周方向に離間している。 As shown in FIG. 3, on the edge of the opening of the smaller resin case 2b (on the right side in the drawing), two arcuately curved plate-shaped engaging protrusions 3 and 3 along the shape of the edge are integrally formed. It is rushed. The two engaging protrusions 3, 3 are provided at positions separated from each other along the circular edge of the opening so as to face opposite sides in the radial direction. Two curved engaging claws 3a and 3a are provided on the outer side of each of the engaging protrusions 3 and 3 in the radial direction. The two engaging claws 3a and 3a of each engaging protrusion 3 are separated from each other in the circumferential direction.

大きい方（図示左側）の樹脂ケース２ａの開口部の縁には、樹脂ケース２ｂの４つの係合爪３ａにそれぞれ対応して、４つの係合爪５ａ（２つのみ図示）が内側に向けて突設されている。各係合爪５ａは、開口部の形状に合わせて湾曲しており、周方向に互いに離間して設けられている。４つの係合爪５ａのそれぞれの内側に対向した位置には、開口部の縁に沿って湾曲した押え板５が設けられている。 At the edge of the opening of the resin case 2a on the larger side (left side in the figure), four engaging claws 5a (only two are shown) face inward corresponding to the four engaging claws 3a of the resin case 2b. It is projected. Each engaging claw 5a is curved according to the shape of the opening, and is provided apart from each other in the circumferential direction. A holding plate 5 curved along the edge of the opening is provided at a position facing the inside of each of the four engaging claws 5a.

また、樹脂ケース２ａの開口部の縁には、２つの比較的長い円弧状の凹部１１、１１が設けられている。これら２つの凹部１１は、樹脂ケース２ａの開口部の縁のうち上述した係合爪５ａおよび押え板５を設けていない互いに径方向に対向する位置に設けられている。図４に示すように２つの樹脂ケース２ａ、２ｂを嵌合させた状態で、これら２つの凹部１１、１１は、後述する薬剤担持体Ｂの密封袋Ｆの両端を挿通するためのスリット１３、１３として機能する。スリット１３を通して薬剤担持体が容器２の外に出ないように、凹部１１の深さは、薬剤担持体の径より小さくされている。 Further, two relatively long arcuate recesses 11 and 11 are provided on the edge of the opening of the resin case 2a. These two recesses 11 are provided at positions on the edge of the opening of the resin case 2a, which are not provided with the above-mentioned engaging claws 5a and the holding plate 5, and face each other in the radial direction. As shown in FIG. 4, in a state where the two resin cases 2a and 2b are fitted, these two recesses 11 and 11 are slits 13 for inserting both ends of the sealing bag F of the drug carrier B described later. Functions as 13. The depth of the recess 11 is made smaller than the diameter of the drug carrier so that the drug carrier does not come out of the container 2 through the slit 13.

２つの樹脂ケース２ａ、２ｂの開口部を重ねて２つの樹脂ケース２ａ、２ｂを嵌合させる場合、小さい方の樹脂ケース２ｂの係合突起３が大きい方の樹脂ケース２ａの開口部の縁と押え板５との間の隙間に挿入されて押し込まれ、樹脂ケース２ｂの４つの係合爪３ａと樹脂ケース２ａの４つの係合爪５ａがそれぞれ係合する。これにより、２つの樹脂ケース２ａ、２ｂが一体化され、図４に示すような球状の容器２が形成される。 When the openings of the two resin cases 2a and 2b are overlapped and the two resin cases 2a and 2b are fitted, the engaging protrusion 3 of the smaller resin case 2b is with the edge of the opening of the larger resin case 2a. It is inserted into the gap between the presser plate 5 and pushed in, and the four engaging claws 3a of the resin case 2b and the four engaging claws 5a of the resin case 2a are engaged with each other. As a result, the two resin cases 2a and 2b are integrated to form a spherical container 2 as shown in FIG.

このように２つの樹脂ケース２ａ、２ｂを嵌合させた状態で、押え板５は、係合爪３ａ、５ａによる係合を保持するように係合突起３の変形を抑え、樹脂ケース２ａ、２ｂの分離を不可能にしている。しかし、押え板５を無くして樹脂ケース２ａ、２ｂを分離可能としてもよい。 In the state where the two resin cases 2a and 2b are fitted in this way, the holding plate 5 suppresses the deformation of the engaging projection 3 so as to hold the engagement by the engaging claws 3a and 5a, and the resin case 2a, It makes it impossible to separate 2b. However, the presser plate 5 may be eliminated so that the resin cases 2a and 2b can be separated.

ところで、２つの樹脂ケース２ａ、２ｂは、可撓性を有する板状の連結部材１により連結されている。連結部材１の一端は、一方の係合突起３の径方向の外側で樹脂ケース２ｂの開口部の縁近くの外面に一体に固定されている。連結部材１の他端は、２枚の押え板５の間で樹脂ケース２ａの開口部の縁近くの外面に一体に固定されている。すなわち、連結部材１は、この連結部材１を折り曲げて２つの樹脂ケース２ａ、２ｂを嵌合したとき、それぞれ対応する４組の係合爪３ａ、５ａが対向する位置に設けられている。 By the way, the two resin cases 2a and 2b are connected by a plate-shaped connecting member 1 having flexibility. One end of the connecting member 1 is integrally fixed to the outer surface near the edge of the opening of the resin case 2b on the outer side in the radial direction of one of the engaging protrusions 3. The other end of the connecting member 1 is integrally fixed to the outer surface near the edge of the opening of the resin case 2a between the two pressing plates 5. That is, the connecting member 1 is provided at a position where the corresponding four sets of engaging claws 3a and 5a face each other when the connecting member 1 is bent to fit the two resin cases 2a and 2b.

より詳細には、図３に示すように、連結部材１は、３つの肉厚部分７ａ、７ｂ、７ｃを２つの肉薄部分８ａ、８ｂを介して一列に交互に連結した構造を有する。すなわち、肉厚部分７ａの一端（図示左端）が樹脂ケース２ａの外面に一体に連結され、肉厚部分７ａの他端と肉厚部分７ｂの一端が肉薄部分８ａを介して折り曲げ可能に連結され、肉厚部分７ｂの他端と肉厚部分７ｃの一端が肉薄部分８ｂを介して折り曲げ可能に連結され、肉厚部分７ｃの他端（図示右端）が樹脂ケース２ｂの外面に一体に連結されている。 More specifically, as shown in FIG. 3, the connecting member 1 has a structure in which three thick portions 7a, 7b, 7c are alternately connected in a row via two thin portions 8a, 8b. That is, one end of the thick portion 7a (left end in the drawing) is integrally connected to the outer surface of the resin case 2a, and the other end of the thick portion 7a and one end of the thick portion 7b are foldably connected via the thin portion 8a. The other end of the thick portion 7b and one end of the thick portion 7c are foldably connected via the thin portion 8b, and the other end of the thick portion 7c (right end in the figure) is integrally connected to the outer surface of the resin case 2b. ing.

連結部材１は、２つの樹脂ケース２ａ、２ｂとともに１種類の樹脂による一体成形により形成される。よって、肉薄部分８ａ、８ｂの曲げ易さは、肉薄部分８ａ、８ｂの厚みを選択することで調整される。本実施形態では、比較的ヒンジ特性のある（折り曲げに強い）ポリプロピレンやポリエチレンなどにより２つの樹脂ケース２ａ、２ｂ、および連結部材１を形成した。本実施形態では、肉薄部分８ａ、８ｂの厚さを０．２ｍｍ～０．５ｍｍ程度に形成した。 The connecting member 1 is integrally molded with one type of resin together with the two resin cases 2a and 2b. Therefore, the bendability of the thin portions 8a and 8b is adjusted by selecting the thickness of the thin portions 8a and 8b. In the present embodiment, the two resin cases 2a and 2b and the connecting member 1 are formed of polypropylene, polyethylene, or the like having relatively hinge characteristics (resistant to bending). In the present embodiment, the thickness of the thin portions 8a and 8b is formed to be about 0.2 mm to 0.5 mm.

３つの肉厚部分７ａ、７ｂ、７ｃは、それ自体が殆ど変形不能な厚さを有し、図４に示すように連結部材１を環状に湾曲させたときに円筒をなすように、それぞれ、同じ面側に湾曲している。本実施形態では、肉厚部分７ａ、７ｂ、７ｃの厚さを０．７ｍｍ～１．５ｍｍ程度に形成した。 The three thick portions 7a, 7b, and 7c each have a thickness that is almost non-deformable in themselves, and form a cylinder when the connecting member 1 is curved in an annular shape as shown in FIG. 4, respectively. It is curved to the same surface side. In the present embodiment, the thickness of the thick portions 7a, 7b, and 7c is formed to be about 0.7 mm to 1.5 mm.

各肉厚部分７ａ、７ｂ、７ｃが肉薄部分８ａ、８ｂに連絡する端部には、肉厚の違いに応じた段部が設けられている。２つの肉薄部分８ａ、８ｂは、図４に示す環状にしたときに、３つの肉厚部分７ａ、７ｂ、７ｃの外面１ａと面一になる外面を有する。このため、段部は、肉厚部分と肉薄部分の間の内面１ｂ側に形成される。 At the end where the thick portions 7a, 7b, 7c communicate with the thin portions 8a, 8b, a step portion corresponding to the difference in wall thickness is provided. The two thin portions 8a and 8b have an outer surface that is flush with the outer surfaces 1a of the three thick portions 7a, 7b and 7c when formed into an annular shape as shown in FIG. Therefore, the step portion is formed on the inner surface 1b side between the thick portion and the thin portion.

言い換えると、この段部には、肉厚部分７ａ、７ｂ、７ｃの肉薄部分８ａ、８ｂをつないだ接触端面９が設けられる。肉厚部分７ａ、７ｂ、７ｃの接触端面９は、肉厚部分７ａ、７ｂ、７ｃの曲率（すなわち図４の円筒の曲率）に応じた半径方向に延設した平らな傾斜面であり、図４に示すように連結部材１を円筒状に湾曲させたとき、隣接する肉厚部分７ａ、７ｂ、７ｃの接触端面９同士が面で接触する。 In other words, the step portion is provided with a contact end surface 9 connecting the thin portions 8a, 8b of the thick portions 7a, 7b, 7c. The contact end surface 9 of the thick portions 7a, 7b, 7c is a flat inclined surface extending in the radial direction according to the curvature of the thick portions 7a, 7b, 7c (that is, the curvature of the cylinder in FIG. 4). When the connecting member 1 is curved in a cylindrical shape as shown in 4, the contact end faces 9 of the adjacent thick portions 7a, 7b, and 7c come into contact with each other in a plane.

つまり、図４に示すように連結部材１を環状にすると、肉薄部分８ａを介して隣接する２つの肉厚部分７ａ、７ｂの接触端面９、９が面で接触して互いに押圧され、肉薄部分８ｂを介して隣接する２つの肉厚部分７ｂ、７ｃの接触端面９、９が面で接触して互いに押圧される。これにより、円筒形にした連結部材１の内面１ｂが段差なくなめらかにつながった円筒面を形成する。このため、円筒状の連結部材１にゴム紐６を挿通したとき、ゴム紐６の摩耗を抑制することができ、ゴム紐６の使用寿命を延長することができる。 That is, when the connecting member 1 is made annular as shown in FIG. 4, the contact end surfaces 9 and 9 of the two adjacent thick portions 7a and 7b are brought into contact with each other via the thin portion 8a and pressed against each other, and the thin portion is formed. The contact end faces 9 and 9 of the two adjacent thick portions 7b and 7c are brought into contact with each other and pressed against each other via the 8b. As a result, a cylindrical surface is formed in which the inner surface 1b of the cylindrical connecting member 1 is smoothly connected without a step. Therefore, when the rubber cord 6 is inserted through the cylindrical connecting member 1, the wear of the rubber cord 6 can be suppressed and the service life of the rubber cord 6 can be extended.

また、２つの樹脂ケース２ａ、２ｂを図３に示すように展開した状態で、連結部材１の２つの肉薄部分８ａ、８ｂは、３つの肉厚部分７ａ、７ｂ、７ｃと同じ面側、すなわち図４に示す環状にした状態で外面１ａ側に突出するように湾曲している。このため、連結部材１を図４に示すように円筒形に丸めたとき、連結部材１の外面１ａがなめらかな円筒表面となり、見た目がきれいに見える。また、肉薄部分８ａ、８ｂを外面１ａ側に突出するように湾曲させておくことで、肉薄部分８ａ、８ｂを折り曲げて連結部材１を環状にしたときに、肉薄部分８ａ、８ｂが切れ難く且つ曲がり易くすることができる。 Further, in a state where the two resin cases 2a and 2b are unfolded as shown in FIG. 3, the two thin portions 8a and 8b of the connecting member 1 are on the same surface side as the three thick portions 7a, 7b and 7c, that is, It is curved so as to project toward the outer surface 1a in the annular state shown in FIG. Therefore, when the connecting member 1 is rolled into a cylindrical shape as shown in FIG. 4, the outer surface 1a of the connecting member 1 becomes a smooth cylindrical surface, and the appearance looks beautiful. Further, by bending the thin portions 8a and 8b so as to project toward the outer surface 1a, when the thin portions 8a and 8b are bent to form the connecting member 1 in an annular shape, the thin portions 8a and 8b are difficult to cut. It can be easily bent.

以下、上述した構造の容器２内に収容する薬剤担持体の密封袋について、いくつかの実施形態を例示して説明する。例えばマイクロカプセルを用いて芳香剤や消臭剤などの薬剤Ｙを担持した薬剤担持体Ｂは、不所望なタイミングで薬剤Ｙの揮散が開始しないように、密閉した袋に収容した状態で容器２内に収容される。そして、薬剤揮散具１０の使用を開始する際に、密封袋を破封して薬剤担持体Ｂを容器２内に放出するようにしている。 Hereinafter, some embodiments of the sealed bag of the drug carrier to be housed in the container 2 having the above-mentioned structure will be described as an example. For example, the drug carrier B carrying the drug Y such as a fragrance or a deodorant using microcapsules is housed in a sealed bag so that the drug Y does not volatilize at an undesired timing. It is housed inside. Then, when the drug volatilizer 10 is started to be used, the sealed bag is broken and the drug carrier B is discharged into the container 2.

（第１の実施形態）
図５は、第１の実施形態に係る密封袋２０を示す外観図である。密封袋２０は透明な樹脂フィルムにより形成されているため、内部に収容した薬剤担持体Ｂを外側から見ることができる。図４では、この密封袋２０の両端２０ａ、２０ｂがスリット１３、１３から容器２の外にそれぞれ突出した状態を示している。スリット１３は、密封袋２０を抜き取るための抜き取り孔として機能するとともに、密封袋２０の一部を導出する導出孔としても機能する。また、図６は、密封袋２０を内部に収容した未使用状態の容器２を図４のＦ６－Ｆ６に沿って切断した断面図である。 (First Embodiment)
FIG. 5 is an external view showing the sealed bag 20 according to the first embodiment. Since the sealing bag 20 is made of a transparent resin film, the drug carrier B housed inside can be seen from the outside. FIG. 4 shows a state in which both ends 20a and 20b of the sealed bag 20 protrude from the slits 13 and 13 to the outside of the container 2, respectively. The slit 13 functions as a pull-out hole for pulling out the sealed bag 20, and also functions as a lead-out hole for drawing out a part of the sealed bag 20. Further, FIG. 6 is a cross-sectional view of an unused container 2 containing the sealed bag 20 inside, cut along F6-F6 of FIG.

図５に示すように、密封袋２０は、例えば、１枚の矩形の樹脂フィルムを筒状にして２つの端辺を重ねてシール部Ｓ１でシールし、筒状にした樹脂フィルム（以下、筒状フィルムと称する）の両端をシール部Ｓ２でそれぞれシールした構造を有する。薬剤担持体Ｂは、シール部Ｓ１でシールした筒状フィルムの一端をシール部Ｓ２でシールした後、他端側から筒状フィルム内に挿入される。その後、筒状フィルムの他端がシール部Ｓ２でシールされる。 As shown in FIG. 5, the sealing bag 20 is, for example, a resin film in which one rectangular resin film is formed into a tubular shape, two ends thereof are overlapped and sealed by a sealing portion S1 to form a tubular resin film (hereinafter, a cylinder). It has a structure in which both ends of a plastic film) are sealed by a sealing portion S2. The drug carrier B is inserted into the tubular film from the other end side after sealing one end of the tubular film sealed by the sealing portion S1 with the sealing portion S2. After that, the other end of the tubular film is sealed by the sealing portion S2.

密封袋２０は、例えば、ポリエチレン、ポリプロピレン、ポリエチレンテレフタレートなどの透明な樹脂フィルムを用いて、シール部Ｓ１、Ｓ２にて２枚重ねた樹脂フィルムを熱溶着により接着することで形成される。シール部Ｓ１、Ｓ２における接着は、熱溶着に限らず接着剤を用いた接着などを採用してもよい。 The sealing bag 20 is formed by, for example, using a transparent resin film such as polyethylene, polypropylene, or polyethylene terephthalate, and adhering two resin films stacked on the sealing portions S1 and S2 by heat welding. Adhesion in the seal portions S1 and S2 is not limited to heat welding, and adhesion using an adhesive or the like may be adopted.

シール部Ｓ１、Ｓ２のうち少なくとも一方のシール部Ｓ２における樹脂フィルムの接着強度は、比較的弱くされており、内部に収容した薬剤担持体Ｂを密封袋２０の内側からシール部Ｓ２に押し付けることで破封される程度に設定されている。この場合、シール部Ｓ２（および／或いはＳ１）は、破袋容易部として機能する。 The adhesive strength of the resin film in at least one of the sealing portions S1 and S2 is relatively weak, and the drug carrier B contained therein is pressed against the sealing portion S2 from the inside of the sealing bag 20. It is set to the extent that it will be broken. In this case, the seal portion S2 (and / or S1) functions as a bag-breaking portion.

密封袋２０内に収容した薬剤担持体Ｂは、例えば、薬剤を封入したマイクロカプセルを含むスラリーを香料含浸体に含浸させたものである。香料含浸体として、例えば、多孔性セルロース粒子であるビスコパール（商品名）、紙、多孔性ケイ酸カルシウム粒子であるフローライト、ＥＶＡ（エチレン酢酸ビニルコポリマー）ビーズなどが用いられる。マイクロカプセルは、外部から圧力が加えられた際に破袋して内部に封入した薬剤を放出する。マイクロカプセルを含むスラリーは、香料含浸体に含浸され表面に塗布されているため、香料含浸体の外部から圧力が加わった際にマイクロカプセルが破袋するようになっている。この際、外部からの圧力は、摩擦などの接触による加圧を含む。 The drug carrier B housed in the sealed bag 20 is, for example, a fragrance-impregnated body impregnated with a slurry containing microcapsules containing a drug. As the fragrance impregnated body, for example, viscopearl (trade name) which is a porous cellulose particle, paper, Florite which is a porous calcium silicate particle, EVA (ethylene vinyl acetate copolymer) beads and the like are used. When pressure is applied from the outside, the microcapsules break the bag and release the drug encapsulated inside. Since the slurry containing the microcapsules is impregnated with the fragrance impregnated body and applied to the surface, the microcapsules are designed to break when pressure is applied from the outside of the fragrance impregnated body. At this time, the pressure from the outside includes pressurization due to contact such as friction.

上記のように複数個の薬剤担持体Ｂを収容して密封した密封袋２０は、図４および図６に示す状態で容器２内に収容保持される。まず、図３に示すように容器２を展開した２つの樹脂ケース２ａ、２ｂのうち大きい方の樹脂ケース２ａの中に密封袋２０を入れ、密封袋２０の両端２０ａ、２０ｂを幅が狭くなるように縮めて２つの凹部１１にそれぞれ乗せて外部へ突出させる。この状態で、小さい方の樹脂ケース２ｂを樹脂ケース２ａに嵌合する。これにより、両端２０ａ、２０ｂがスリット１３、１３から外側に突出した状態で、密封袋２０が容器２内に保持される。 The sealed bag 20 containing and sealing the plurality of drug carriers B as described above is stored and held in the container 2 in the state shown in FIGS. 4 and 6. First, as shown in FIG. 3, the sealed bag 20 is placed in the larger resin case 2a of the two resin cases 2a and 2b in which the container 2 is developed, and the widths of both ends 20a and 20b of the sealed bag 20 are narrowed. It is shrunk so as to be placed on each of the two recesses 11 and protruded to the outside. In this state, the smaller resin case 2b is fitted into the resin case 2a. As a result, the sealed bag 20 is held in the container 2 with both ends 20a and 20b protruding outward from the slits 13 and 13.

密封袋２０の幅は、スリット１３の幅Ｗ（図３）より大きくされている。ここで言うスリット１３の幅Ｗとは、スリット１３の両端間の直線距離である。このように、密封袋２０の幅をスリット１３より大きくすることで、未使用状態（図４、図６に示す状態）において、密封袋２０の両端２０ａ、２０がスリット１３を通る部位に皺がより、スリット１３を介して密封袋２０の端部２０ａ、２０ｂが容器２内へ落ちる不具合を防止することができる。また、密封袋２０の幅を大きくすることで、筒状フィルム内に薬剤担持体Ｂを収容する際に、開口部を比較的大きくすることができ、作業性を高めることができる。 The width of the sealed bag 20 is made larger than the width W of the slit 13 (FIG. 3). The width W of the slit 13 referred to here is a straight line distance between both ends of the slit 13. By making the width of the sealed bag 20 larger than that of the slit 13 in this way, wrinkles are formed in the portions where both ends 20a and 20 of the sealed bag 20 pass through the slit 13 in the unused state (states shown in FIGS. 4 and 6). Therefore, it is possible to prevent the end portions 20a and 20b of the sealed bag 20 from falling into the container 2 through the slit 13. Further, by increasing the width of the sealing bag 20, the opening can be made relatively large when the drug carrier B is housed in the tubular film, and workability can be improved.

また、本実施形態では、上述した未使用状態で密封袋２０の端部２０ａ、２０ｂが容器２内に落ちないように、容器２の容積に対して、密封袋２０に収容する薬剤担持体Ｂの量を多目に設定した。密封袋２０に収容する薬剤担持体Ｂの数が少ないと、容器２と密封袋２０との間に大きな空間ができ、密封袋２０の両端２０ａ、２０ｂをスリット１３に挿通した状態で、薬剤担持体Ｂの重さによって密封袋２０が容器２の内面に向けて垂れ下がる距離が長くなる。つまり、この場合、密封袋２０の端部２０ａ、２０ｂ容器２内に引き込まれる量が多くなり、端部２０ａ、２０ｂがスリット１３から抜け易くなる。よって、本実施形態では、薬剤担持体Ｂの数を多目にして、自重により垂れ下がる距離を短くした。 Further, in the present embodiment, the drug carrier B accommodated in the sealed bag 20 with respect to the volume of the container 2 so that the ends 20a and 20b of the sealed bag 20 do not fall into the container 2 in the unused state described above. The amount of was set to a large value. If the number of drug carriers B accommodated in the sealed bag 20 is small, a large space is created between the container 2 and the sealed bag 20, and the drug is carried with both ends 20a and 20b of the sealed bag 20 inserted through the slit 13. The weight of the body B increases the distance that the sealed bag 20 hangs down toward the inner surface of the container 2. That is, in this case, the amount of the sealed bag 20 drawn into the end portions 20a and 20b container 2 increases, and the end portions 20a and 20b can easily come out of the slit 13. Therefore, in the present embodiment, the number of the drug carriers B is increased to shorten the hanging distance due to its own weight.

反面、図６に示すように、密封袋２０の両端２０ａ、２０ｂをスリット１３、１３によって保持した状態で、容器２の内面と密封袋２０の間に隙間が存在すると、薬剤揮散具１０の輸送時、または薬剤揮散具１０を落下させてしまったときなどに、薬剤担持体Ｂへ加えられる衝撃を和らげることができる。このため、薬剤担持体Ｂの個数は、図６の状態に密封袋２０をスリット１３、１３によって保持した状態で、容器２と密封袋２０との間にある程度の空間が形成される程度の個数にすることが望ましい。 On the other hand, as shown in FIG. 6, when a gap exists between the inner surface of the container 2 and the sealed bag 20 in a state where both ends 20a and 20b of the sealed bag 20 are held by the slits 13 and 13, the drug volatilizer 10 is transported. It is possible to soften the impact applied to the drug carrier B at times, or when the drug volatilizer 10 is dropped. Therefore, the number of the drug carriers B is such that a certain space is formed between the container 2 and the sealed bag 20 in the state where the sealed bag 20 is held by the slits 13 and 13 in the state shown in FIG. Is desirable.

この他に、密封袋２０の両端２０ａ、２０ｂがスリット１３、１３から脱落しないようにするため、密封袋２０の樹脂フィルム自体を厚くしたり、スリット１３の高さを端部２０ａ、２０ｂが通過可能な最低限の高さに設定したりする方法も考えられる。また、密封袋２０の両端２０ａ、２０ｂのスリット１３から外方へ突出する長さを長くすることでもスリット１３からの脱落を防止することができる。
In addition, in order to prevent both ends 20a and 20b of the sealed bag 20 from falling off from the slits 13 and 13, the resin film itself of the sealed bag 20 may be thickened, or the ends 20a and 20b may pass through the height of the slit 13. It is also possible to set it to the minimum possible height. Further, it is also possible to prevent the sealed bag 20 from falling off from the slit 13 by increasing the length of the sealed bag 20 protruding outward from the slits 13 of both ends 20a and 20b.

以下、図７を参照して、上述した未使用状態の容器２における密封袋２０の破封方法について説明する。
まず、図７（ａ）に示すように、容器２の一方（図示右側）のスリット１３（抜き取り孔）から外方へ突出している密封袋２０の一端２０ｂを引っ張る。これにより、密封袋２０の他端２０ａが容器２内に入り、薬剤担持体Ｂが他端２０ａ側に片寄る。一端２０ｂを引っ張ることで、密封袋２０の容積が徐々に小さくなる。 Hereinafter, a method of breaking the sealed bag 20 in the above-mentioned unused container 2 will be described with reference to FIG. 7.
First, as shown in FIG. 7A, one end 20b of the sealed bag 20 protruding outward from the slit 13 (extraction hole) on one side (right side in the drawing) of the container 2 is pulled. As a result, the other end 20a of the sealed bag 20 enters the container 2, and the drug carrier B is offset toward the other end 20a. By pulling one end 20b, the volume of the sealed bag 20 gradually decreases.

そして、密封袋２０の容積が薬剤担持体Ｂが占める空間の容積より小さくなると、図７（ｂ）に示すように、密封袋２０の内圧が高まり、他端２０ａにあるシール部Ｓ２が剥離して密封袋２０が破封され、薬剤担持体Ｂが容器２内に放出される。このとき、シール部Ｓ２が剥離することに加えてシール部Ｓ１が剥離する場合があり、或いはシール部Ｓ２の代りにシール部Ｓ１が剥離する場合がある。なお、薬剤担持体Ｂは、スリット１３を通過不能な大きさを有する必要がある。 When the volume of the sealed bag 20 becomes smaller than the volume of the space occupied by the drug carrier B, the internal pressure of the sealed bag 20 increases and the seal portion S2 at the other end 20a is peeled off, as shown in FIG. 7B. The sealed bag 20 is ruptured and the drug carrier B is released into the container 2. At this time, the seal portion S1 may be peeled off in addition to the seal portion S2 being peeled off, or the seal portion S1 may be peeled off instead of the seal portion S2. The drug carrier B needs to have a size that does not allow it to pass through the slit 13.

さらに一端２０ｂを引っ張ると、図７（ｃ）に示すように、密封袋２０の樹脂フィルムがスリット１３から完全に引き抜かれ、容器２から分離される。この状態で、薬剤担持体Ｂが容器２内に放出されて空気に触れ、容器２内で移動可能となり、薬剤Ｙの揮散が開始される。 When one end 20b is further pulled, as shown in FIG. 7C, the resin film of the sealed bag 20 is completely pulled out from the slit 13 and separated from the container 2. In this state, the drug carrier B is released into the container 2 and comes into contact with air, becomes movable in the container 2, and volatilization of the drug Y is started.

以上のように、本実施形態によると、容器２の２つのスリット１３、１３のうち一方のスリット１３から外方へ突出した密封袋２０の端部２０ｂ（或いは２０ａ）を引っ張るだけで、密封袋２０の樹脂フィルムだけを容器２から分離させることができる。このため、薬剤担持体Ｂを容器２内に確実且つ容易に放出することができ、薬剤Ｙの揮散を確実に開始することができる。 As described above, according to the present embodiment, the sealed bag is simply pulled by pulling the end portion 20b (or 20a) of the sealed bag 20 protruding outward from one of the two slits 13 and 13 of the container 2. Only 20 resin films can be separated from the container 2. Therefore, the drug carrier B can be reliably and easily released into the container 2, and the volatilization of the drug Y can be reliably started.

また、本実施形態によると、薬剤揮散具１０の使用開始時において、使用者が薬剤担持体Ｂに触れることがないため、使用者が薬剤担持体Ｂに担持された薬剤Ｙに触れたり、薬剤担持体Ｂを容器２外に落下させるといった不具合を防止することができる。 Further, according to the present embodiment, since the user does not touch the drug carrier B at the start of use of the drug volatilizer 10, the user touches the drug Y carried on the drug carrier B or the drug. It is possible to prevent a problem such as dropping the carrier B out of the container 2.

また、本実施形態によると、薬剤Ｙの揮散開始時に密封袋２０の樹脂フィルムをスリット１３から抜き取るため、薬剤揮散具１０の使用終了時に容器２を開けて樹脂フィルムを取り出す必要がなく、廃棄処理を容易にすることができる。 Further, according to the present embodiment, since the resin film of the sealed bag 20 is removed from the slit 13 at the start of volatilization of the drug Y, it is not necessary to open the container 2 and take out the resin film at the end of use of the drug volatilizer 10, and the disposal process is performed. Can be facilitated.

さらに、本実施形態によると、従来のように、ガス透過性フィルムを用いる必要がないため、薬剤担持体Ｂに担持させる薬剤Ｙの種類を自由に選択することができ、薬剤揮散具１０としてあらゆる薬剤Ｙを揮散させることができる。 Further, according to the present embodiment, since it is not necessary to use a gas permeable film as in the conventional case, the type of the drug Y to be supported on the drug carrier B can be freely selected, and any of the drug volatilizers 10 can be used. The drug Y can be volatilized.

なお、上述した第１の実施形態では、薬剤担持体Ｂを樹脂フィルムで密封した密封袋２０の両端２０ａ、２０ｂをスリット１３から外方へ導出させた場合について説明したが、これに限らず、容器２に単一のスリット１３を設けて密封袋２０の一端を当該スリット１３から導出させてもよい。この場合、密封袋２０の他端は容器２内に位置することになり、密封袋２０を破封する際には、単一のスリット１３から導出している密封袋２０の端部を引き抜くことになる。 In the first embodiment described above, the case where both ends 20a and 20b of the sealed bag 20 in which the drug carrier B is sealed with a resin film is led out from the slit 13 has been described, but the present invention is not limited to this. A single slit 13 may be provided in the container 2 and one end of the sealed bag 20 may be led out from the slit 13. In this case, the other end of the sealed bag 20 is located inside the container 2, and when the sealed bag 20 is broken, the end of the sealed bag 20 led out from the single slit 13 is pulled out. become.

（第２の実施形態）
図８は、第２の実施形態に係る密封袋３０を示す外観図である。密封袋３０は、上述した第１の実施形態の密封袋２０と同様に容器２に収容され、薬剤揮散具１０の使用開始時に破袋される。 (Second embodiment)
FIG. 8 is an external view showing the sealed bag 30 according to the second embodiment. The sealed bag 30 is housed in the container 2 in the same manner as the sealed bag 20 of the first embodiment described above, and is broken at the start of use of the drug volatilizer 10.

本実施形態の密封袋３０は、例えば、内部に複数個の薬剤担持体Ｂを収容した状態で、矩形の樹脂フィルムを中央で２つ折りにして、解放した３辺において重なったシール部Ｓ３で樹脂フィルム同士を溶着することで形成される。また、密封袋３０は、容器２内に収容して両端３０ａ、３０ｂをスリット１３、１３から外方へ突出させた状態で、容器２の外側に配置される２つの切り欠きＫ、Ｋを有する。切り欠きＫは、密封袋３０の長手方向の両端３０ａ、３０ｂに近接して、密封袋３０のシール部Ｓ３に設けられている。 In the sealed bag 30 of the present embodiment, for example, in a state where a plurality of drug carriers B are housed inside, a rectangular resin film is folded in half at the center, and a resin is formed by a sealing portion S3 that overlaps on three released sides. It is formed by welding films together. Further, the sealed bag 30 has two notches K and K arranged on the outside of the container 2 in a state of being housed in the container 2 and having both ends 30a and 30b protruding outward from the slits 13 and 13. .. The notch K is provided in the seal portion S3 of the sealed bag 30 in the vicinity of both ends 30a and 30b in the longitudinal direction of the sealed bag 30.

上記の密封袋３０を容器２内に収容した薬剤揮散具１０を使用する場合、まず、図９（ａ）に示すように、一方（図示左側）のスリット１３（導出孔）から外方へ突出した密封袋３０の端部３０ａの近くにある切り欠きＫから密封袋３０の一部を切り裂いて破袋させる。容器２内に収容されている薬剤担持体Ｂは、スリット１３を通過不能な大きさを有する。このため、密封袋３０を破袋しても薬剤担持体Ｂが容器２の外部へ放出されることはない。 When using the drug volatilizer 10 in which the above-mentioned sealed bag 30 is housed in the container 2, first, as shown in FIG. 9A, it protrudes outward from the slit 13 (outlet hole) on one side (left side in the drawing). A part of the sealed bag 30 is torn from the notch K near the end portion 30a of the sealed bag 30 to break the bag. The drug carrier B housed in the container 2 has a size that cannot pass through the slit 13. Therefore, even if the sealed bag 30 is broken, the drug carrier B is not released to the outside of the container 2.

この後、図９（ｂ）に示すように、切り裂いた端部３０ａと反対側の密封袋３０の端部３０ｂを引っ張って、密封袋３０の樹脂フィルムをスリット１３から抜き取る。このとき、第１の実施形態と同様に、薬剤担持体Ｂは、容器２内に残る。 After that, as shown in FIG. 9B, the end portion 30b of the sealing bag 30 on the opposite side to the torn end portion 30a is pulled, and the resin film of the sealing bag 30 is pulled out from the slit 13. At this time, the drug carrier B remains in the container 2 as in the first embodiment.

さらに、樹脂フィルムを引っ張ると、図９（ｃ）に示すように、密封袋３０の樹脂フィルムが容器２から完全に分離される。 Further, when the resin film is pulled, the resin film of the sealed bag 30 is completely separated from the container 2 as shown in FIG. 9 (c).

以上のように、本実施形態においても、上述した第１の実施形態と同様に、密封袋３０の樹脂フィルムを容器２から容易に抜き取ることができ、薬剤Ｙの揮散を確実に開始させることができる。 As described above, also in the present embodiment, the resin film of the sealed bag 30 can be easily removed from the container 2 and the volatilization of the drug Y can be reliably started, as in the first embodiment described above. can.

（第３の実施形態）
図１０は、第３の実施形態に係る密封袋４０を示す外観図である。
密封袋４０は、切り欠きＫの代りに長手方向の中央にミシン目Ｔを有する以外、上述した第２の実施形態の密封袋３０と同じ構造を有する。よって、ここでは、第２の実施形態と同様に機能する構成には同一符号を付してその詳細な説明を省略する。 (Third embodiment)
FIG. 10 is an external view showing the sealed bag 40 according to the third embodiment.
The sealing bag 40 has the same structure as the sealing bag 30 of the second embodiment described above, except that the sealing bag 40 has a perforation T in the center in the longitudinal direction instead of the notch K. Therefore, here, the same reference numerals are given to the configurations that function in the same manner as in the second embodiment, and detailed description thereof will be omitted.

密封袋４０を破袋して薬剤揮散具１０の使用を開始する場合、容器２の２つのスリット１３からそれぞれ外方へ突出した密封袋４０の端部４０ａ、４０ｂを両手で逆方向に引っ張る。これにより、ミシン目Ｔで密封袋４０の樹脂フィルムが裂けて２つに分離される。分離された２つの樹脂フィルムは、それぞれ、スリット１３を介して容器２から引き抜かれる。これにより、薬剤担持体Ｂが容器２内に放出され、薬剤Ｙの揮散が開始される。 When the sealing bag 40 is broken and the drug volatilizer 10 is started to be used, the ends 40a and 40b of the sealing bag 40 protruding outward from the two slits 13 of the container 2, respectively, are pulled in the opposite directions with both hands. As a result, the resin film of the sealing bag 40 is torn at the perforation T and separated into two. The two separated resin films are each pulled out from the container 2 through the slit 13. As a result, the drug carrier B is released into the container 2, and the volatilization of the drug Y is started.

以上のように、本実施形態においても、上述した第１および第２の実施形態と同様の効果を奏することができる。 As described above, also in this embodiment, the same effects as those in the first and second embodiments described above can be obtained.

以上、いくつかの実施形態に基づいて本発明を説明したが、本発明は、上述した実施形態に限定されるものではなく、本発明の要旨の範囲内で種々の変形や応用が可能なことは勿論である。 Although the present invention has been described above based on some embodiments, the present invention is not limited to the above-described embodiments, and various modifications and applications are possible within the scope of the gist of the present invention. Of course.

例えば、上述した実施形態では、密封袋２０、３０、４０の樹脂フィルムを容器２から抜き取る抜き取り孔として、２つのスリット１３、１３を容器２に設けた場合について説明したが、これに限らず、樹脂フィルムの抜き取り孔の形状はいかなる形状であってもよく、少なくとも薬剤担持体Ｂが通過不能な大きさであればよい。
以下、本願の出願当初の特許請求の範囲に記載された発明を付記する。
［１］
揮発性を有する薬剤を担持した薬剤担持体を封入した密封袋と、
前記薬剤担持体が通過不能で且つ前記密封袋を抜き取り可能な大きさの抜き取り孔を有し、前記密封袋の一部を前記抜き取り孔から外部へ突出させた状態で、前記薬剤担持体を収容した前記密封袋を収容した容器と、
を有する薬剤揮散具。
［２］
前記容器に設けた揮散孔をさらに有する、
［１］の薬剤揮散具。
［３］
前記密封袋は、前記抜き取り孔から突出した前記密封袋の一部を引っ張ることで破袋する破袋容易部を有する、
［１］の薬剤揮散具。
［４］
前記破袋容易部は、前記密封袋のシール部である、
［３］の薬剤揮散具。
［５］
前記破袋容易部は、前記密封袋に設けたミシン目である、
［３］の薬剤揮散具。
［６］
前記容器は、前記薬剤担持体が通過不能で且つ前記密封袋の他の一部を外部へ導出可能な大きさの導出孔をさらに有し、
前記導出孔から外部へ導出された前記密封袋の他の一部に、当該密封袋を破袋するための切り欠きを有する、
［１］の薬剤揮散具。 For example, in the above-described embodiment, the case where the two slits 13 and 13 are provided in the container 2 as the extraction holes for extracting the resin films of the sealed bags 20, 30 and 40 from the container 2 has been described, but the present invention is not limited to this. The shape of the extraction hole of the resin film may be any shape, and may be at least a size that the drug carrier B cannot pass through.
Hereinafter, the inventions described in the scope of claims at the time of filing the application of the present application will be added.
[1]
A sealed bag containing a drug carrier carrying a volatile drug,
The drug carrier is accommodated in a state in which the drug carrier has a withdrawal hole of a size that does not allow passage and the sealed bag can be pulled out, and a part of the sealed bag is projected outward from the withdrawal hole. The container containing the sealed bag and
Drug volatilizer with.
[2]
Further having a volatilization hole provided in the container,
The drug volatilizer of [1].
[3]
The sealed bag has an easy bag breaking portion that breaks by pulling a part of the sealed bag protruding from the extraction hole.
The drug volatilizer of [1].
[4]
The easy-to-break portion is a sealing portion of the sealed bag.
[3] Drug volatilizer.
[5]
The easy-to-break portion is a perforation provided in the sealed bag.
[3] Drug volatilizer.
[6]
The container further has a lead-out hole sized so that the drug carrier cannot pass through and the other part of the sealed bag can be led out to the outside.
The other part of the sealed bag led out from the lead-out hole has a notch for breaking the sealed bag.
The drug volatilizer of [1].

２、４…容器、 ２ａ、２ｂ…樹脂ケース、 ２ｃ…揮散孔、 ６…ゴム紐、 １０…薬剤揮散具、 １３…スリット、 ２０、３０、４０…密封袋、 ２０ａ、２０ｂ、３０ａ、３０ｂ、４０ａ、４０ｂ…端部、 Ｂ…薬剤担持体、 Ｋ…切り欠き、 Ｓ１～Ｓ３…シール部、 Ｔ…ミシン目。 2, 4 ... Container, 2a, 2b ... Resin case, 2c ... Volatilization hole, 6 ... Rubber string, 10 ... Chemical volatilizer, 13 ... Slit, 20, 30, 40 ... Sealed bag, 20a, 20b, 30a, 30b, 40a, 40b ... end, B ... drug carrier, K ... notch, S1-S3 ... seal, T ... perforation.

Claims (5)

揮発性を有する薬剤を担持した薬剤担持体を封入した密封袋と、
前記密封袋の幅より狭い幅を有するとともに前記薬剤担持体が通過不能で且つ前記密封袋を抜き取り可能な大きさを有する抜き取り孔、及び薬剤を揮散させるための揮散孔を有し、前記密封袋の一部を前記抜き取り孔から外部へ突出させた状態で、前記密封袋を収容した容器と、
を有する薬剤揮散具。 A sealed bag containing a drug carrier carrying a volatile drug,
The sealed bag has a width narrower than the width of the sealed bag, a sampling hole having a size that the drug carrier cannot pass through and a size that allows the sealed bag to be pulled out , and a volatilization hole for volatilizing the drug. With a part of the bag protruding outward from the extraction hole, the container containing the sealed bag and the container.
Drug volatilizer with. 前記密封袋は、前記抜き取り孔から突出した前記密封袋の一部を引っ張ることで破袋する破袋容易部を有する、
請求項１の薬剤揮散具。 The sealed bag has an easy bag breaking portion that breaks by pulling a part of the sealed bag protruding from the extraction hole.
The drug volatilizer according to claim 1. 前記破袋容易部は、前記密封袋のシール部である、
請求項２の薬剤揮散具。 The easy-to-break portion is a sealing portion of the sealed bag.
The drug volatilizer according to claim 2 . 前記破袋容易部は、前記密封袋に設けたミシン目である、
請求項２の薬剤揮散具。 The easy-to-break portion is a perforation provided in the sealed bag.
The drug volatilizer according to claim 2 . 前記容器は、前記薬剤担持体が通過不能で且つ前記密封袋の他の一部を外部へ導出可能な大きさの導出孔をさらに有し、
前記導出孔から外部へ導出された前記密封袋の他の一部に、当該密封袋を破袋するための切り欠きを有する、
請求項１の薬剤揮散具。
The container further has a lead-out hole sized so that the drug carrier cannot pass through and the other part of the sealed bag can be led out to the outside.
The other part of the sealed bag led out from the lead-out hole has a notch for breaking the sealed bag.
The drug volatilizer according to claim 1.
JP2017187934A 2017-09-28 2017-09-28 Chemical volatilizer Active JP7027093B2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2017187934A JP7027093B2 (en) 2017-09-28 2017-09-28 Chemical volatilizer
PCT/JP2018/029628 WO2019064941A1 (en) 2017-09-28 2018-08-07 Chemical agent volatilizing instrument

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2017187934A JP7027093B2 (en) 2017-09-28 2017-09-28 Chemical volatilizer

Publications (2)

Publication Number Publication Date
JP2019058612A JP2019058612A (en) 2019-04-18
JP7027093B2 true JP7027093B2 (en) 2022-03-01

Family

ID=65901608

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017187934A Active JP7027093B2 (en) 2017-09-28 2017-09-28 Chemical volatilizer

Country Status (2)

Country Link
JP (1) JP7027093B2 (en)
WO (1) WO2019064941A1 (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001151605A (en) 1999-11-30 2001-06-05 S T Chem Co Ltd Volatillizer of chemical and indicator
JP2003189778A (en) 2001-10-15 2003-07-08 Earth Chem Corp Ltd Container of insect repellent
JP2012025431A (en) 2010-07-23 2012-02-09 Kyoto Refre Shinyaku Kk Container body, container, and method of unsealing bag
JP2014111474A (en) 2012-10-19 2014-06-19 Dainippon Jochugiku Co Ltd Medicine container
WO2017094673A1 (en) 2015-12-01 2017-06-08 アース製薬株式会社 Container body

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001151605A (en) 1999-11-30 2001-06-05 S T Chem Co Ltd Volatillizer of chemical and indicator
JP2003189778A (en) 2001-10-15 2003-07-08 Earth Chem Corp Ltd Container of insect repellent
JP2012025431A (en) 2010-07-23 2012-02-09 Kyoto Refre Shinyaku Kk Container body, container, and method of unsealing bag
JP2014111474A (en) 2012-10-19 2014-06-19 Dainippon Jochugiku Co Ltd Medicine container
WO2017094673A1 (en) 2015-12-01 2017-06-08 アース製薬株式会社 Container body

Also Published As

Publication number Publication date
JP2019058612A (en) 2019-04-18
WO2019064941A1 (en) 2019-04-04

Similar Documents

Publication Publication Date Title
US6705541B2 (en) Fragrance dispenser
KR101981728B1 (en) Child-resistant and senior-friendly eco-friendly pill dispenser blister package
US7926735B1 (en) Fragrance package, dispenser, and method
US10850291B2 (en) Pump dispenser and system comprising a refill cartridge and the pump dispenser
KR20150103123A (en) Device for delivering a volatile fluid to the atmosphere
KR20150103124A (en) Method for delivering a volatile fluid to the atmosphere
JPWO2013132782A1 (en) Wet tissue packaging
JP4832983B2 (en) container
US20170144176A1 (en) Refill Cartridge and System Comprising the Refill Cartridge and a Pump Dispenser
JP6662628B2 (en) Volatilization vessel
JP7027093B2 (en) Chemical volatilizer
US20120153038A1 (en) Scent-releasing apparatus and method of making same
JP5365391B2 (en) Drug container and package using the same
JP6338841B2 (en) Drug container
JP2007525271A (en) Discharge device
JPS58212737A (en) Gasfying apparatus
JP7126815B2 (en) chemical volatilizer
JPH08294Y2 (en) Tissue paper packaging box
JP5583671B2 (en) Packaging unit
JP2015037956A (en) Aroma discharge tool
JP2012076762A (en) Aromatic substance container
JP2001219977A (en) Package for gradually releasing gas
JP6786319B2 (en) Chemical volatilizer
JP2021048815A (en) Chemical agent volatilizing body
JP2006273395A (en) Packaging film

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20200805

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20210706

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210901

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20220118

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20220216

R150 Certificate of patent or registration of utility model

Ref document number: 7027093

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250